Actor Chris Hemsworth explores ways to unlock longevity in a six-part series for Disney +, pushing his mind and body to live a better, healthier, and longer life. “Limitless” was released in November 2022 and every episode challenges Hemsworth to discover his body’s potential, including going on an off-grid adventure to future-proof his brain and learning to control stress by walking on a crane from a great height.
Several companies are investing millions in healthcare and technology to study, understand, and ultimately improve biological age for people around the world. Launched in the UK in 2022, Altos Labs began studying biological reprogramming to prolong human life. Venture capital firm Healthspan Capital has invested and supported a range of companies studying longevity biology – or LongBio, as the company calls it – since 2021.
“Longevity biotech ("LongBio") will revolutionize biomedicine by bringing aging under medical control. The traditional pharma model of 'sickness management' will be gradually replaced with the LongBio approach of targeting the root cause of disease,” Sebastian A. Brunemeier, general partner and co-founder of Healthspan Capital, tells VML Intelligence. Brunemeier predicts that “new tools like gene and cell therapy will enable more precise reprogramming of biology that will make our history of pills and plant extracts look medieval by comparison.”
Technology and research in prolonging healthspans are still limited and in their infancy, however health-conscious consumers are willing to learn and spend on ways to prolong life and reinforce healthy living.
